5 unchanged sentences
Because shares of our common stock are held by depositaries, brokers and other nominees, the number of beneficial holders of our shares is larger than the number of stockholders of record.
−Removed: Stock Performance Graph
−Removed: The following graph shows the value of an investment of $100 on December 31, 2016 in each of CytoSorbents Corporation common stock, the Russell 2000 Index and the Nasdaq Biotech Index.
−Removed: All values assume reinvestment of the pretax value of dividends and are calculated as of December 31 st of each year.
−Removed: The historical stock price performance of the Company’s common stock shown in the performance graph is not necessarily indicative of future stock price performance.
−Removed: CytoSorbents Corporation vs.
−Removed: Russell 2000 Index and Nasdaq Biotech Index
−Removed: Comparison of 5 Year Total Cumulative Return
−Removed: Value of a $100 Investment on December 31, 2016
Issuer Purchases of Securities
2 unchanged sentences
We had no sales of unregistered securities in 2022 that have not been previously disclosed in a Current Report on Form 8-K or Quarterly Report on Form 10-Q.
−Removed: Selected Financial Data.
−Removed: The following table summarizes our selected financial data for the periods and as of the dates indicated, which have been derived from our audited financial statements and related notes and should be read together with the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and with our consolidated financial statements and related notes, which are included elsewhere in this Annual Report.
−Removed: Total revenue
−Removed: Cost of revenue
−Removed: Operating expenses:
−Removed: Research and development
−Removed: Legal, financial and other consulting
−Removed: Selling general and administrative
−Removed: Total operating expenses
−Removed: Loss from operations
−Removed: Other income (expense):
−Removed: Interest income (expense), net
−Removed: Foreign currency transaction gain (loss)
−Removed: Total other income (expense), net
−Removed: Loss before benefit from income taxes
−Removed: Benefit from income taxes
−Removed: Net loss available to common stockholders, basic and diluted
−Removed: Weighted average common shares outstanding, basic and diluted
−Removed: Net loss per share, basic and diluted
−Removed: As of December 31,
−Removed: Consolidated Balance Sheet Data:
−Removed: Cash and cash equivalents
−Removed: Working capital
−Removed: Preferred stock
−Removed: Accumulated deficit
−Removed: (221,185,295)
−Removed: (196,626,647)
−Removed: (188,789,459)
−Removed: (169,523,815)
−Removed: (152,312,636)
−Removed: Total stockholders’ equity
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.